In A Market Collapse, Where Are The Bargains? 2 Mispriced Opportunities Worth Considering (Podcast)

| About: Akorn, Inc. (AKRX)


Sifting the world from Romania to the US.

Our top 2016 takeout candidate: Akorn.

Why closed-end funds are often mispriced.

Rangeley Capital's portfolio managers Andrew Walker and Chris DeMuth Jr host a fifteen-minute podcast, which you can subscribe to on Stitcher (we are also on iTunes and SoundCloud). If you missed the previous podcast episode, then please check out "Buffett Likes Berkshire; Should You?"

In the past, I have written about the potential for a market collapse and how you might prepare. In particular, I want to be focused on where bargains might be hidden. Today, I am focused on two favorite bargains that offer terrific entry points and expected values.

In the current episode, we discuss a fund set up to compensate Romanians who suffered under communism. Then, we discuss our favorite takeout candidate for 2016: Akorn (NASDAQ:AKRX). We wrap up by discussing closed-end funds, their shady IPOs, and subsequent opportunities.

Disclosure: I am/we are long AKRX.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: Chris DeMuth Jr and Andrew Walker are portfolio managers at Rangeley Capital. Rangeley invests with a margin of safety by buying securities at deep discounts to their intrinsic value and unlocking that value through corporate events. In order to maximize total returns for our investors, we reserve the right to make investment decisions regarding any security without further notification except where such notification is required by law.

About this article:

Author payment: $35 + $0.01/page view. Authors of PRO articles receive a minimum guaranteed payment of $150-500.
Tagged: , Drugs - Generic,
Want to share your opinion on this article? Add a comment.
Disagree with this article? .
To report a factual error in this article, click here